Skip to main content
# Title Research Member Research Year
51 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute
Dr. Azaa Shibl Sayed Mahmoud 2019
52 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute
Prof. Heba Abdel-Razik Sayed Hussein 2019
53 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute
Prof. Heba Abdel-Razik Sayed Hussein 2019
54 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Dr. Khaled Fathy Riad Osman 2018
55 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Samar Muhammad mansour 2018
56 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
Prof. Heba Abdel-Razik Sayed Hussein 2018
57 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
Prof. Amany Mohamed Ali Ahmed 2018
58 HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute Dr. Khaled Fathy Riad Osman 2018
59 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Shaimaa / Elsayyed Youssef / Ahmed 2018
60 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
Prof. Heba Abdel-Razik Sayed Hussein 2018